← Browse by Condition
Medical Condition

follicular lymphoma grade iii

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT02393157 Phase 2
Recruiting

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Enrollment
25 pts
Location
United States
Sponsor
New York Medical College
View Trial →